Carbon Commitment

To achieve Net Zero, and in line with the Science Based Targets, initiative SBTO, we have adopted the following carbon reduction targets:

  • We are committing to reduce our Scope 2 emissions by at least 45% by 2030 and 90% by 2040
  • We are committing to reduce our Scope 3 emissions by at least 30% by 2030 and 90% by 2045

At ADAllen Pharma, our mission goes beyond supplying comparator drugs for clinical trials. We are committed to advancing global health while promoting sustainability, ethical practices, and social responsibility across everything we do.

Caring for People and the Planet

We believe that a healthier world starts with responsible action. From how we operate to how we partner, we strive to create lasting value for society and the environment.

Our People, Our Purpose

We put people first—starting with our team.
We foster a purpose-driven culture that supports growth, diversity, and wellbeing. Our employees are empowered to contribute meaningfully to global healthcare progress.

Sustainable Supply, Resilient Operations

Efficient. Ethical. Environmentally conscious.
We are reducing our environmental impact through responsible sourcing, optimized logistics, and continuous improvement of our global operations.

Health Equity and Community Impact

We support clinical trials that lead to safer, more effective treatments—helping to broaden access to quality healthcare worldwide. Our work helps improve outcomes for diverse patient populations, globally.

Partnering for Positive Change

Through collaboration with clients, manufacturers, and healthcare providers, we’re building a future where clinical advancement and corporate responsibility go hand in hand.

Speak to an expert to source comparator drugs